Distrobird — Free Sales Engagement Platform
Sequences, cloud call center, shared inbox, form tracking and more — on a single platform. Double your sales team's output with fewer tools.
Create a sequence — it's free
Itolerance, Inc.
itolerance is a privately held regenerative medicine company enabling tissue, organoid or cell therapy without the need for life-long immunosuppression. leveraging our proprietary technology platform, itol-100, we are advancing a pipeline of programs using both allogenic pancreatic islets and stem-cells that have the potential to cure diseases. our lead program, itol-101 is being developed for type 1 diabetes and in a preclinical non-human primate study, pancreatic islet cells co-implanted with itol-101 exhibited long-term function with control of blood glucose levels and restoration of insulin secretion without the use of chronic immune suppression. our follow-on candidate, itol-102 is leveraging significant advancements in stem cells, which allows a potentially inexhaustible supply of insulin-producing cells for use in type 1 diabetes. additionally, the company is developing itol-201 for liver failure and itol-301 as a potential regenerative protein and cell therapy that leverages st
Frequently asked questions about Itolerance, Inc.
Let us help answer the most common questions you might have.
Where is Itolerance, Inc. located?
Itolerance, Inc.'s headquarters is located at Miami, Florida, United States, 33136
What is Itolerance, Inc.'s official website?
Itolerance, Inc.'s official website is itolerance.com
How many employees does Itolerance, Inc. have?
Itolerance, Inc. has 4 employees
What are Itolerance, Inc.'s social media links?
Itolerance, Inc. Linkedin page
Distrobird — Free Sales Engagement Platform
Sequences, cloud call center, shared inbox, form tracking and more — on a single platform. Double your sales team's output with fewer tools.
Create a sequence — it's free
